AYTU BIOPHARMA, INC Quarterly Return On Equity in % from Q1 2022 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Aytu Biopharma, Inc quarterly/annual Return On Equity history and growth rate from Q1 2022 to Q3 2023.
  • Aytu Biopharma, Inc Return On Equity for the quarter ending September 30, 2023 was -61.9 %, a 51.5% increase year-over-year.
  • Aytu Biopharma, Inc annual Return On Equity for 2023 was -39.1 %, a 71.3% increase from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -61.9 +65.7 +51.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 -39.1 +97.3 +71.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -68.4 +39.9 +36.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -157 Oct 1, 2022 Dec 31, 2022
Q3 2022 -128 Jul 1, 2022 Sep 30, 2022
Q2 2022 -136 Apr 1, 2022 Jun 30, 2022
Q1 2022 -108 Jan 1, 2022 Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.